kabutan

Welby Inc.(4438) Summary

4438
TSE Growth
Welby Inc.
294
JPY
0
(0.00%)
Jan 29, 3:24 pm JST
1.92
USD
Jan 29, 1:24 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
7.07
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:36 am
293 JPY 1.91 USD
Previous Close Jan 28
294 JPY 1.92 USD
High Jan 29, 10:08 am
296 JPY 1.93 USD
Low Jan 29, 9:36 am
293 JPY 1.91 USD
Volume
3,500
Trading Value
1.00M JPY 6.73K USD
VWAP
294.37 JPY 1.92 USD
Minimum Trading Value
29,400 JPY 192 USD
Market Cap
2.43B JPY 0.02B USD
Number of Trades
25
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
155
1-Year High Mar 21, 2025
4,695
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 247,300
Jan 16, 2026 0 264,000
Jan 9, 2026 0 271,500
Dec 26, 2025 0 261,700
Dec 19, 2025 0 269,800
Company Profile
Welby Inc. provides personal health management platforms for lifestyle-related diseases and other conditions, primarily serving pharmaceutical companies, medical institutions, and healthcare-related organizations.
Sector
Information & Communication
Welby Inc. develops and operates PHR (Personal Health Record) platform services to support self-management for patients with lifestyle-related diseases and various other conditions. The company primarily works on commission from pharmaceutical companies to develop and manage platforms that promote proper use of new drugs and raise disease awareness upon market launch. Additionally, through its proprietary service "Welby MyKarte," the company supports self-management for patients with lifestyle-related diseases. These services facilitate information sharing between patients and healthcare professionals, contributing to treatment continuity and promoting self-health management. Revenue primarily consists of service development fees and usage fees from pharmaceutical companies, as well as charges to health insurance associations and corporations. With patient consent, accumulated data is also made available for sharing with healthcare professionals and for academic purposes.